Eduardo Dunayevich, MD
Neurocrine Biosciences, Inc., San Diego, California
- 7Articles
- 21.4KReads
- 2000–2026Active
- 42Collaborators
- 1.4KCitations
About
Eduardo Dunayevich, MD, is affiliated with Neurocrine Biosciences, Inc. in San Diego, California. Dr. Dunayevich has contributed to research on schizophrenia, schizoaffective disorders, anxiety, bipolar disorder, tardive dyskinesia, and weight. Publications span from 2000 to 2026 in Psychiatrist.com (The Journal of Clinical Psychiatry and The Primary Care Companion for CNS Disorders).
Publications
Validation for the Tardive Dyskinesia Impact Scale, a Patient-Reported Outcome Measure in Valbenazine Clinical Trials
April 29, 2026
Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder: Results of a Pilot Study
June 20, 2013
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.